The World: New York - Novartis picks DDB Worldwide in $350m review

The pharmaceutical manufacturer Novartis AG has added DDB Worldwide to its roster following a review of its $350 million global ad business.

DDB has been selected to work with its Omnicom sibling, the healthcare specialist Cline Davis & Mann.

As part of the review, Novartis has also reappointed the New York outfit Deutsch, which handles below-the-line ads for the Zelnorm and Lamisil brands.